CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
Our COVID-19 Evidence Portal contains the latest COVID-19 information from CADTH and other respected organizations. Content is updated daily to reflect the rapidly changing and increasing international scientific evidence related to this disease.
The following is a summary of the most recent information posted to our COVID-19 portal.
- This report provides information on ongoing randomized controlled trials of drugs being investigated to treat or prevent COVID-19.
- It will be updated every 2 weeks.
- Ongoing trials of vaccines and plasma-based therapies are addressed in separate CADTH reports.
Visit our COVID-19 news page to stay on top of all the emerging information we are monitoring and updating. Here’s the latest news:
- SARS-CoV2 Neutralizing Antibody: Bamlanivimab for the Prevention of COVID-19
On January 21, 2021, a press release describing the results of the BLAZE-2 study was made available.
- Therapeutic Anticoagulation With Heparin and Low-Molecular-Weight Heparin
On January 22, 2021, a press release about interim results on the efficacy of full-dose anticoagulation therapy with heparin or low-molecular-weight heparin in patients hospitalized with COVID-19 was made available.
On January 23, 2021, a press release about results of the efficacy of colchicine in outpatients with COVID-19 were made available.
CADTH Literature Searching Tools
CADTH is pleased to showcase additional COVID-19 resources from our partner organizations and the Canadian federal, provincial, and territorial governments’ health jurisdictions:
CAN’T FIND WHAT YOU NEED? LET US KNOW
Canadian ministries and departments of health, publicly funded organizations responsible for health service delivery, and clinical society stakeholders are encouraged to submit a request or contact their CADTH Liaison Officer. We’re here to help.
The CADTH Weekly COVID-19 Update is intended to keep you informed about the latest information posted on the CADTH COVID-19 portal. You’re receiving this update because you’ve subscribed to our CADTH e-alert system.